Extreme genetic risk for type 1A diabetes
- PMID: 16966600
- PMCID: PMC1563993
- DOI: 10.1073/pnas.0606349103
Extreme genetic risk for type 1A diabetes
Abstract
Type 1A diabetes (T1D) is an autoimmune disorder the risk of which is increased by specific HLA DR/DQ alleles [e.g., DRB1*03-DQB1*0201 (DR3) or DRB1*04-DQB1*0302 (DR4)]. The genotype associated with the highest risk for T1D is the DR3/4-DQ8 (DQ8 is DQA1*0301, DQB1*0302) heterozygous genotype. We determined HLA-DR and -DQ genotypes at birth and analyzed DR3/4-DQ8 siblings of patients with T1D for identical-by-descent HLA haplotype sharing (the number of haplotypes inherited in common between siblings). The children were clinically followed with prospective measurement of anti-islet autoimmunity and for progression to T1D. Risk for islet autoimmunity dramatically increased in DR3/4-DQ8 siblings who shared both HLA haplotypes with their diabetic proband sibling (63% by age 7, and 85% by age 15) compared with siblings who did not share both HLA haplotypes with their diabetic proband sibling (20% by age 15, P < 0.01). 55% sharing both HLA haplotypes developed diabetes by age 12 versus 5% sharing zero or one haplotype (P = 0.03). Despite sharing both HLA haplotypes with their proband, siblings without the HLA DR3/4-DQ8 genotype had only a 25% risk for T1D by age 12. The risk for T1D in the DR3/4-DQ8 siblings sharing both HLA haplotypes with their proband is remarkable for a complex genetic disorder and provides evidence that T1D is inherited with HLA-DR/DQ alleles and additional MHC-linked genes both determining major risk. A subset of siblings at extremely high risk for T1D can now be identified at birth for trials to prevent islet autoimmunity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



References
-
- Onengut-Gumuscu S, Concannon P. Immunol Rev. 2002;190:182–194. - PubMed
-
- Anjos S, Polychronakos C. Mol Genet Metab. 2004;81:187–195. - PubMed
-
- Pugliese A. Endocrinol Metab Clin North Am. 2004;33:1–16, vii. - PubMed
-
- Lambert AP, Gillespie KM, Thomson G, Cordell HJ, Todd JA, Gale EA, Bingley PJ. J Clin Endocrinol Metab. 2004;89:4037–4043. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK032083/DK/NIDDK NIH HHS/United States
- N01 AI015416/AI/NIAID NIH HHS/United States
- R37 DK032493/DK/NIDDK NIH HHS/United States
- M01 RR00069/RR/NCRR NIH HHS/United States
- M01 RR000051/RR/NCRR NIH HHS/United States
- R37 DK032083/DK/NIDDK NIH HHS/United States
- P30DK57516/DK/NIDDK NIH HHS/United States
- R01 DK032493/DK/NIDDK NIH HHS/United States
- AI50964/AI/NIAID NIH HHS/United States
- P30 DK057516/DK/NIDDK NIH HHS/United States
- DK32493/DK/NIDDK NIH HHS/United States
- DK32083/DK/NIDDK NIH HHS/United States
- M01 RR000069/RR/NCRR NIH HHS/United States
- M01 RR00051/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials